Mexico Approves the World’s First RNA Biofungicide, Drawing a US$100 Million Bet
Mexico · Agriculture
Key Facts
- World first Mexico’s Cofepris granted the world’s first sanitary registration for an RNA-based biofungicide, announced 12 August 2026.
- Target crops It is aimed at fungal disease across crops, with reporting citing grapes plus avocado, strawberry, cucumber, tomato and squash; no single fungus or efficacy figure was disclosed.
- How it works RNA silences a gene the fungus needs to survive, acting only on that fungus and degrading naturally in soil, water and fruit.
- Regulatory review Cofepris granted the registration in coordination with Senasica and Semarnat; officials stress the RNA acts only on the target fungus and degrades naturally.
- Investment GreenLight Biosciences will invest close to US$100 million in a Mexico City plant.
- Company lead Founder and CEO Andrey Zarur announced the manufacturing plans alongside the approval.
- No trade name The specific commercial product name was not confirmed in available reporting.
The real story here isn’t just a new spray — it’s a shift in how regulators and growers think about crop protection. If this works at scale, it could change the economics of high-value crops and the environmental math of farming across the region.
You’ve probably heard about RNA in the context of vaccines or gene therapy. Now imagine the same principle turned against the fungi that ruin crops — and Mexico just became the first country in the world to approve that as a commercial farming tool. The RNA biofungicide, developed by GreenLight Biosciences, is designed to fight fungal disease across crops that reporting says include grapes, avocado, strawberry and cucumber, and the company says it will invest close to US$100 million to build a production plant in Mexico City. This isn’t a niche lab experiment; it’s a regulatory green light that could reshape how Latin America’s agricultural sector thinks about chemical inputs.

What exactly is an RNA biofungicide?
RNA — ribonucleic acid — is a molecule found naturally in every living cell. In this case, the biofungicide uses a piece of RNA designed to carry a specific biological instruction to the target fungus. That instruction effectively switches off a gene the fungus needs to survive. Think of it as sending a corrupted blueprint to a construction crew: the crew gets the message, tries to build, and fails because the plan is wrong.
Mexican regulators described the mechanism as one that “turns off the fungus’s gene” needed for survival. Crucially, the RNA is selective — it only affects the target fungus, not other organisms. After doing its job, the molecule degrades naturally in soil, water and fruit. That means no persistent residue, no bioaccumulation in the food chain, and no lingering toxicity for non-target organisms.
Why this matters beyond one crop
Conventional chemical fungicides are broad-spectrum tools. They kill the target pathogen, but they can also harm beneficial fungi, disrupt soil ecosystems, and leave residues that regulators and consumers increasingly frown upon. For a reader living in or invested in Latin America, this matters because agriculture is the region’s economic backbone — and the pressure to reduce chemical inputs is coming from every direction: export markets, domestic regulators, and a global consumer base that reads labels.
If this RNA biofungicide performs in the field as it did in trials, it offers a path to maintain high yields while dramatically lowering environmental impact. That’s not just a feel-good story; it’s a competitive advantage. Growers who can claim cleaner production methods may access premium markets or avoid future restrictions on chemical residues. And the fact that the manufacturing plant will be in Mexico City means local supply chains, local jobs, and a shorter distance between production and application — a logistical win for growers across North and Central America.
The regulatory path and what it signals
Cofepris, Mexico’s health-risk regulator, led the approval process, with input from Senasica (the agriculture food safety agency) and Semarnat (the environment ministry). That three-agency review is worth noting: it signals that this wasn’t a rubber-stamp approval. The review weighed the product’s selectivity and its full lifecycle, from application to natural degradation in soil, water and fruit.
For anyone following biotech regulation in Latin America, this is a landmark. Mexico is often seen as a cautious market when it comes to novel agricultural technologies. By being the first to approve an RNA-based biofungicide, it’s sending a message that it’s open to innovation — provided the science holds up. That could encourage other companies to bring similar products to the region, and it could pressure other Latin American regulators to develop frameworks for RNA-based crop protection rather than waiting for approvals elsewhere.
What happens next — and what to watch
GreenLight Biosciences’ investment of close to US$100 million in a Mexico City plant is a vote of confidence in the market. But building a facility takes time, and scaling up production from lab to industrial volumes is a different challenge than getting regulatory approval. Watch for announcements about construction timelines, production capacity, and when the product will actually be available to growers.
Also worth watching: whether other countries in Latin America follow Mexico’s lead. Argentina, Brazil and Chile all have large, export-driven farm sectors. If the RNA biofungicide proves itself in Mexican fields, expect pressure on regulators elsewhere to fast-track similar approvals. The technology is transferable, the regulatory precedent is set, and the market demand for cleaner crop protection isn’t going away.
Frequently Asked Questions
Is this the same as genetic modification?
No. The RNA biofungicide does not alter the DNA of the fungus or the plant. It works by temporarily silencing a gene in the fungus using a natural molecule. The RNA degrades quickly in the environment, so there’s no lasting genetic change.
Will this replace all chemical fungicides?
Not immediately. The product is aimed at fungal disease and is expected to be used across several crops, including grapes. Other pathogens and crops will still need different treatments. But if the technology proves reliable, it could be adapted to other pathogens over time.
Is the product safe for people and animals?
Mexican regulators approved the product, and officials say the RNA acts only on the target fungus and degrades naturally in soil, water and fruit, leaving no persistent residue. As with any agricultural input, proper application practices will still matter.
Connected Coverage
Sources: Cofepris; Senasica; Semarnat; Once Noticias; Zócalo; Excélsior; Infobae; GreenLight Biosciences.
This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error
Read More from The Rio Times